GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 424 filers reported holding GLOBUS MED INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,194,200 | -38.6% | 588,000 | -26.4% | 0.12% | -35.1% |
| Q2 2023 | $47,573,710 | +1402.8% | 799,021 | +1329.6% | 0.19% | +1264.3% |
| Q1 2023 | $3,165,723 | +677.8% | 55,892 | +919.9% | 0.01% | +600.0% |
| Q4 2022 | $407,000 | -84.2% | 5,480 | -87.4% | 0.00% | -84.6% |
| Q3 2022 | $2,584,000 | +1.2% | 43,382 | -4.6% | 0.01% | 0.0% |
| Q2 2022 | $2,553,000 | -12.7% | 45,482 | +14.7% | 0.01% | +18.2% |
| Q1 2022 | $2,925,000 | +2.2% | 39,642 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $2,862,000 | +46.7% | 39,642 | +55.7% | 0.01% | +22.2% |
| Q3 2021 | $1,951,000 | -1.2% | 25,460 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $1,974,000 | +25.7% | 25,460 | 0.0% | 0.01% | +28.6% |
| Q1 2021 | $1,570,000 | -6.0% | 25,460 | -0.6% | 0.01% | 0.0% |
| Q4 2020 | $1,670,000 | +29.5% | 25,605 | -1.7% | 0.01% | +16.7% |
| Q3 2020 | $1,290,000 | +6.7% | 26,040 | +2.7% | 0.01% | 0.0% |
| Q2 2020 | $1,209,000 | -39.4% | 25,346 | -46.0% | 0.01% | -53.8% |
| Q1 2020 | $1,996,000 | -38.2% | 46,938 | -14.4% | 0.01% | -18.8% |
| Q4 2019 | $3,229,000 | -8.1% | 54,838 | -20.2% | 0.02% | -15.8% |
| Q3 2019 | $3,513,000 | -1.0% | 68,722 | -18.1% | 0.02% | 0.0% |
| Q2 2019 | $3,547,000 | -15.9% | 83,862 | -1.7% | 0.02% | -17.4% |
| Q1 2019 | $4,217,000 | +23.9% | 85,352 | +8.6% | 0.02% | +9.5% |
| Q4 2018 | $3,403,000 | -0.8% | 78,622 | +30.1% | 0.02% | +16.7% |
| Q3 2018 | $3,430,000 | +877.2% | 60,427 | +768.0% | 0.02% | +800.0% |
| Q2 2018 | $351,000 | +1.2% | 6,962 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $347,000 | +21.3% | 6,962 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $286,000 | -53.0% | 6,962 | -66.0% | 0.00% | -50.0% |
| Q3 2017 | $609,000 | +44.7% | 20,486 | +61.2% | 0.00% | +33.3% |
| Q2 2017 | $421,000 | 0.0% | 12,706 | -10.6% | 0.00% | 0.0% |
| Q1 2017 | $421,000 | – | 14,216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |